Helping osteoarthritis patients walk with NSAIDs
Official title: A Rehabilitation Walking Program With the Help of a Transient Intake of Nonsteroidal Anti-inflammatory Drug for Patients With Painful Hip/Knee Osteoarthritis - A Pilot Cohort Study With Objectives of Short Walks in the Real Life.
Run by University Hospital, Clermont-Ferrand · NCT05761015 · Data updated 2026-11-12
This study is testing a new program that combines special exercises and occasional use of pain relief medications to help people with hip or knee osteoarthritis walk better.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 50 Years to 70 Years |
| Sex | All |
| Enrollment | 55 (estimated) |
| Sponsor | University Hospital, Clermont-Ferrand Academic / other |
| Locations | 1 site (Clermont-Ferrand) |
| Status | Recruiting |
| Started | December 14, 2023 |
| Main results expected | April 2028 |
| Study ends | April 2028 |
| Registry record updated | February 27, 2026 |
| Trial ID | NCT05761015 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals with unilateral or bilateral hip or knee osteoarthritis experiencing moderate pain while walking.
✕Probably not a fit
Patients with secondary osteoarthritis or those unable to walk without support devices may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to improve walking ability in patients with painful hip or knee osteoarthritis through a multimodal rehabilitation program combined with intermittent use of nonsteroidal anti-inflammatory drugs (NSAIDs). The study involves a single-center, non-randomized, open-label design where participants will undergo assessments and interventions over a 12-week period. Patients will receive tailored footwear, education on managing pain and side effects, and will track their pain and activity levels throughout the study. The goal is to optimize pain relief while minimizing the risks associated with continuous NSAID use.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the quality of life for osteoarthritis patients by improving their ability to walk with reduced pain.
How similar studies have gone: While the use of NSAIDs in osteoarthritis management is common, this specific multimodal approach is novel and has not been extensively tested in previous studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Uni- or bilateral hip or knee idiopathic osteoarthrosis (ACR criteria, Kellgren-Lawrence grade 2 or more on recent X-ray), responsible for pain since 3 at least months, and pain at walking which intensity is at least 4/10 on a numerical rating scale. * Less than 3 relevant walks (at least 20 minutes or 1000 km) a week. * Ability to understand and to follow the protocol, and to answer the questionnaires Exclusion Criteria: * Pregnancy or breastfeeding * Legal protection * Body weight \< 40 kg or underweight * Body weight \>120 kg or obesity * Unability to walk, or unability to walk without support devices (sticks, crutches, orthoses and knee pads are allowed) * Secondary osteoarthrosis (rheumatism, septic arthritis, recent osteonecrosis, hemochromatosis, gout, acromegalia…). * Concomitant general bone disease (Paget, Reiter…). * Concomitant and relevant painful disease else than due to osteoarthrosis (e.g. neuropathic pain, fibromyalgia…) * Previous recent intervention (e.g. surgery, arthroscopy, joint infiltration) expected to relief osteoarthrosis pain throughout the study period. * Planned intervention similar to those abovementioned, during the study period. * Recent initiation of any new analgesic treatment (including systemic steroids). * Planned initiation of any program expected to relief osteoarthrosis pain during the study period, such as physiotherapy, cognitive behavioral therapy…). * Planned major surgery during the study period. * Current cancer disease. * Immunosuppression. * Autoimmune disease. * Concomitant topical or systemic NSAID treatment. * Chronic strong opioid intake. * Concomitant insulin therapy. * Any absolute or relevant contraindication to NSAIDs or acetaminophen, according to the French drug agency
Where it's running
-
CHU Clemront-Ferrand
Clermont-Ferrand, France Recruiting
Study contacts
- Study coordinator: Lise Laclautre
- Email: promo_interne_drci@chu-clermontferrand.fr
- Phone: 04 73 75 11 95
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pain relief for knee osteoarthritis: a 2nd phase study of LY4065967 vs placebo
Researchers are testing whether LY4065967 can help reduce knee pain from osteoarthritis in adults, compared with placebo.
-
Comparing barbed and conventional wound closure after hip or knee replacement
This study will test whether barbed sutures or conventional sutures lead to better wound healing and fewer complications for adults having primary or aseptic revision hip or knee replacement.
-
Evaluating colchicine's effect on knee and hip replacements in osteoarthritis patients
This study is testing if taking colchicine every day can help people with osteoarthritis avoid needing knee or hip replacement surgery.
-
National Registry for Artery Embolization to Treat Chronic Pain
This study is testing if a procedure that blocks blood flow to painful areas can help people with chronic pain from osteoarthritis and other conditions feel better.
-
Personalized rehabilitation care for joint replacement patients
This study is testing whether an AI tool can help create personalized rehab plans for people recovering from hip and knee joint replacement surgeries.
-
Improving sleep to reduce pain after joint surgery
This study is testing if helping people with insomnia sleep better before knee or hip surgery can reduce their pain after the operation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.